Onderneming StemCells Inc Nasdaq
Aandelen
US85857R2040
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 02-08-88 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 01-01-22 |
Chief Tech/Sci/R&D Officer | - | 01/12 | |
Simon Sharon
CTO | Chief Tech/Sci/R&D Officer | 65 | 05-04-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 28-11-16 |
Director/Board Member | 66 | 12-12-17 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 01-08-20 |
Harel Gadot
CEO | Chief Executive Officer | 52 | 02-08-88 |
Yossi Bornstein
FOU | Founder | 66 | 02-08-88 |
Martin Madden
BRD | Director/Board Member | 64 | 06-02-17 |
Director/Board Member | 62 | 01-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 15 965 633 | 15 723 605 ( 98,48 %) | 0 | 98,48 % |
Bedrijfsgegevens
Microbot Medical, Inc.
288 Grove Street Suite 388
02184, Braintree
+781 875 3605
http://microbotmedical.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 46,56 mld. | |
+45,38% | 41,67 mld. | |
+0,69% | 41,16 mld. | |
+30,52% | 32,4 mld. | |
+22,30% | 28,18 mld. | |
-6,35% | 28,1 mld. | |
+49,25% | 14,52 mld. | |
+49,18% | 13,74 mld. | |
+3,45% | 12,17 mld. |
- Beurs
- Aandelen
- Koers MBOT
- Koers
- Onderneming StemCells Inc